Mol. Cell. Biol. doi:10.1128/MCB.01360-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced-Senescence in Pre-lymphomagenic Thymocytes in-vivo
Mai Xu,
Qing Yu,
Ramesh Subrahmanyam,
Michael J. Difilippantonio,
Thomas Ried,
and
Jyoti Misra Sen*
Lymphocyte Development Unit, Laboratory of Immunology, Laboratory of Cellular and Molecular Biology, National Institute on Aging, Baltimore, MD 21224; Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
* To whom correspondence should be addressed. Email:
Jyoti-Sen{at}NIH.GOV.
 |
Abstract |
|---|
Expression of
-Catenin, a potent oncogene, is causally linked to tumorigenesis. Therefore, it was surprising when transgenic expression of oncogenic
-catenin in thymocytes resulted in thymic involution instead of lymphomagenesis. In this report we demonstrate that this is because expression of oncogenic
-catenin induces DNA damage, growth arrest, oncogene-induced-senescence (OIS) and apoptosis of immature thymocytes. In p53-deficient mice, expression of oncogenic
-catenin still results in DNA damage and OIS, but the thymocytes survive and eventually progress to thymic lymphoma.
-Catenin-induced thymic lymphomas are distinct from lymphomas that arise in p53-/- mice. They are CD4-CD8- while p53-dependent lymphomas are largely CD4+CD8+, they develop at an earlier age and in the absence of c-Myc expression or Notch1 signaling. Thus, we report that oncogenic
-catenin-induced, p53-independent growth arrest and OIS and p53-dependent apoptosis protect developing thymocytes from transformation by oncogenic
-catenin.